$0.84
-0.01 (-1.40%)
Open$0.86
Previous Close$0.85
Day High$0.88
Day Low$0.81
52W High$78.90
52W Low$0.82
Volume—
Avg Volume142.8K
Market Cap2.21M
P/E Ratio—
EPS$-294.14
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.86M | 21.34M | 707.3K |
| Net Income | -1,743,661,586 | -3,398,214,437 | 94.3K |
| Profit Margin | -17,689.8% | -16,805.4% | 13.3% |
| EBITDA | -1,825,506,034 | -3,755,371,875 | 212.4K |
| Free Cash Flow | — | — | 76.9K |
| Rev Growth | -53.8% | -53.8% | +7.8% |
| Debt/Equity | 0.08 | 0.08 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |